UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying familial hypercholesterolemia in acute coronary syndrome

Current opinion in lipidology, 2016-08, Vol.27 (4), p.375-381

2016

Volltextzugriff (PDF)

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors

European heart journal, 2017-03, Vol.38 (11), p.814-824

2017

Volltextzugriff (PDF)

Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort

JAMA : the journal of the American Medical Association, 2014-04, Vol.311 (14), p.1416

2014

Volltextzugriff (PDF)

Resting heart rate: what is normal?

Heart (British Cardiac Society), 2018-07, Vol.104 (13), p.1048-1049

Nanchen, David

2018

Volltextzugriff (PDF)

Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality

Annals of internal medicine, 2008-06, Vol.148 (11), p.832

2008

Volltextzugriff (PDF)

Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk

The journal of clinical endocrinology and metabolism, 2012-03, Vol.97 (3), p.852-861

2012

Volltextzugriff (PDF)

Trends in Physical and Cognitive Performance Among Community-Dwelling Older Adults in Switzerland

The journals of gerontology. Series A, Biological sciences and medical sciences, 2020-12, Vol.75 (12), p.2347-2353

2020

Volltextzugriff (PDF)

Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome

PloS one, 2018-04, Vol.13 (4), p.e0195174-e0195174

2018

Volltextzugriff (PDF)

Inflammation during acute coronary syndromes — Risk of cardiovascular events and bleeding

International journal of cardiology, 2019-07, Vol.287, p.13-18

2019

Volltextzugriff (PDF)

Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61

Cardiovascular diabetology, 2019-10, Vol.18 (1), p.142-142, Article 142

2019

Volltextzugriff (PDF)

Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study

Swiss medical weekly, 2019-04, Vol.149, p.w20049

2019

Volltextzugriff (PDF)

PCSK9-Inhibitoren: Entscheidung für das Wohl der Gesellschaft oder von Einzelpersonen?

Swiss medical forum, 2017-11, Vol.17 (45)

Nanchen, David

2017

Volltextzugriff (PDF)

Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention

PloS one, 2019-02, Vol.14 (2), p.e0211464-e0211464

2019

Volltextzugriff (PDF)

Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study

Swiss medical weekly, 2022-07, Vol.152 (2930), p.w30209

2022

Volltextzugriff (PDF)

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes

Journal of the American Heart Association, 2017-11, Vol.6 (11), p.n/a

2017

Volltextzugriff (PDF)

Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study

European journal of heart failure, 2013-05, Vol.15 (5), p.581-588

2013

Volltextzugriff (PDF)

Arterioskleroseprävention ab dem Kindesalter

Swiss medical forum, 2016-10, Vol.16 (42)

Nanchen, David

2016

Volltextzugriff (PDF)

Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes

Atherosclerosis plus, 2024-12, Vol.58, p.1-8

2024

Volltextzugriff (PDF)

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

Atherosclerosis plus, 2021-09, Vol.43, p.24-30

2021

Volltextzugriff (PDF)

Optimal Timing of Invasive Coronary Angiography following NSTEMI

Journal of interventional cardiology, 2020, Vol.2020 (2020), p.1-9

2020

Volltextzugriff (PDF)

Le cholestérol dans l’enfance : est-il utile de le dépister ?

Revue médicale suisse, 2024, Vol.20 (864), p.463-464

2024

Volltextzugriff (PDF)

Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection

Diagnostics (Basel), 2021-03, Vol.11 (4), p.615

2021

Volltextzugriff (PDF)

Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications

PloS one, 2014-03, Vol.9 (3), p.e93147-e93147

2014

Volltextzugriff (PDF)

Is atherosclerosis imaging the most sensitive way to assess patients' risk and the best way to conduct future drug trials? A pros-and-cons debate

Atherosclerosis, 2017-11, Vol.266, p.229-233

2017

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Humans
(80)
Life Sciences & Biomedicine
(75)
Cardiovascular System & Cardiology
(47)
Female
(45)
Cardiac & Cardiovascular Systems
(44)
Male
(43)
Risk Factors
(38)
Middle Aged
(35)
Aged
(34)
Prospective Studies
(29)
Acute Coronary Syndromes
(27)
Acute Coronary Syndrome
(22)
Cardiovascular Disease
(21)
Adult
(18)
Prognosis
(18)
Switzerland
(18)
Cardiovascular Diseases - Prevention & Control
(17)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(17)
Risk Assessment
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Identifying familial hypercholesterolemia in acute coronary syndrome

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors

Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort

Resting heart rate: what is normal?

Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality

Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk

Trends in Physical and Cognitive Performance Among Community-Dwelling Older Adults in Switzerland

Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome

Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes

Inflammation during acute coronary syndromes — Risk of cardiovascular events and bleeding

Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61

Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study

PCSK9-Inhibitoren: Entscheidung für das Wohl der Gesellschaft oder von Einzelpersonen?

Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention

Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes

Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study

Arterioskleroseprävention ab dem Kindesalter

Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

Optimal Timing of Invasive Coronary Angiography following NSTEMI

Le cholestérol dans l’enfance : est-il utile de le dépister ?

Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection

Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications

Is atherosclerosis imaging the most sensitive way to assess patients' risk and the best way to conduct future drug trials? A pros-and-cons debate

Suchergebnisse filtern